Neoprobe reports revenues of $2.7M for first-quarter 2010

[News]

Neoprobe Corporation, a diversified developer of innovative biomedical surgical oncology products, today announced consolidated results for the first quarter of 2010. First quarter 2010 revenues were $2.7 million, consistent with the record revenue reported for the first quarter of 2009.

More... (http://www.news-medical.net/news/20100429/Neoprobe-reports-revenues-of-2427M-for-first-quarter-2010.aspx)